Sputum Microbiome Associates with Pseudomonas aeruginosa Infection Risk in Cystic Fibrosis

Abstract Rationale Pseudomonas aeruginosa (PA) is the archetypal cystic fibrosis (CF) pathogen, and a major contributor to morbidity and mortality. However, predictors of infection risk and persistence remain unclear. This study investigated whether baseline CF sputum microbiome associates with risk of incident PA (iPA) infection and persistence. Methods We conducted a retrospective nested case–control study using a longitudinal sputum biobank. Adults with CF who developed iPA infection (cases) were matched 1:2 to PA-negative controls by sex, age (±2 years), and birth cohort. Microbial community composition was profiled using 16S-rRNA gene sequencing, and PA abundance quantified by qPCR. Longitudinal analyses assessed microbiome changes across pre-infection, at-infection, and post-infection. Key Results In total, 368 sputum samples from 54 cases (85 episodes) and 96 controls (1998–2022) were analysed. Pre-infection community composition differed between cases and controls (PERMAVOVA, R 2 =0.75%, p=0.014). Burkholderia (LFC=1.18, p adj =1.41×10 −5 ) , and Achromobacter (LFC=3.17, p adj =1.51×10 −13 ) were enriched in controls, while Stenotrophomonas (LFC=1.03, p adj =9.16×10 −6 ) was enriched in pre-iPA cases. PA was detected by sequencing (p=0.027) and qPCR (p=0.007) a median of 5.2 months (IQR 3.5–8.7) before culture. At-infection, individuals progressing to chronic infection (n=16) had higher relative (p=0.010) and absolute (p=0.001) PA abundance than transient cases (n=38), with no difference in total bacterial load (p=0.169). Those developing chronic infection exhibited higher Escherichia/Shigella (LFC=4.68, p adj =2.58×10 −4 ) and Stenotrophomonas (LFC=2.78, p adj =0.001). Conclusions CF sputum microbiome composition associates with both risk of acquiring PA and its persistence. These findings suggest microbiome profiling may identify microbial candidates for PA infection risk and may inform future risk stratification.

Authors

Institutions

Publication Details

Journal
ERJ Open Research
Published
2026-08-20
DOI
https://doi.org/10.1183/23120541.00553-2026
Primary Topic
Cystic Fibrosis Research Advances
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sputum Microbiome Associates with Pseudomonas aeruginosa Infection Risk in Cystic Fibrosis

Michael D. Parkins, Nicole Acosta, Barbara J. Waddell, Lauren A. Bowron et al.
ERJ Open Research
Cystic Fibrosis Research Advances
article

Sputum Microbiome Associates with Pseudomonas aeruginosa Infection Risk in Cystic Fibrosis

Michael D. Parkins, Nicole Acosta, Barbara J. Waddell, Lauren A. Bowron, J. Conly, Michael G. Surette, Harvey R. Rabin, Kirsten Ebbert, Luiz Lisboa, Christina S. Thornton, Lalit Bharadwaj
article en

Abstract

Abstract Rationale Pseudomonas aeruginosa (PA) is the archetypal cystic fibrosis (CF) pathogen, and a major contributor to morbidity and mortality. However, predictors of infection risk and persistence remain unclear. This study investigated whether baseline CF sputum microbiome associates with risk of incident PA (iPA) infection and persistence. Methods We conducted a retrospective nested case–control study using a longitudinal sputum biobank. Adults with CF who developed iPA infection (cases) were matched 1:2 to PA-negative controls by sex, age (±2 years), and birth cohort. Microbial community composition was profiled using 16S-rRNA gene sequencing, and PA abundance quantified by qPCR. Longitudinal analyses assessed microbiome changes across pre-infection, at-infection, and post-infection. Key Results In total, 368 sputum samples from 54 cases (85 episodes) and 96 controls (1998–2022) were analysed. Pre-infection community composition differed between cases and controls (PERMAVOVA, R 2 =0.75%, p=0.014). Burkholderia (LFC=1.18, p adj =1.41×10 −5 ) , and Achromobacter (LFC=3.17, p adj =1.51×10 −13 ) were enriched in controls, while Stenotrophomonas (LFC=1.03, p adj =9.16×10 −6 ) was enriched in pre-iPA cases. PA was detected by sequencing (p=0.027) and qPCR (p=0.007) a median of 5.2 months (IQR 3.5–8.7) before culture. At-infection, individuals progressing to chronic infection (n=16) had higher relative (p=0.010) and absolute (p=0.001) PA abundance than transient cases (n=38), with no difference in total bacterial load (p=0.169). Those developing chronic infection exhibited higher Escherichia/Shigella (LFC=4.68, p adj =2.58×10 −4 ) and Stenotrophomonas (LFC=2.78, p adj =0.001). Conclusions CF sputum microbiome composition associates with both risk of acquiring PA and its persistence. These findings suggest microbiome profiling may identify microbial candidates for PA infection risk and may inform future risk stratification.

ERJ Open Research
Alberta Health Services (CA), University of Calgary (CA), Calgary Laboratory Services (CA), McMaster University (CA)
Cystic Fibrosis Foundation
Good health and well-being
Openalex Percentile: Top 10%
Cystic Fibrosis Research Advances
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.